Concepedia

Paul E. Oberstein

PE

Statistics

Publications

43

Citations

7K

H-Index

22

Active since

2011

Affiliations

NYU Langone Health(Current)

Columbia University Irving Medical Center

Columbia University

New York University

Johns Hopkins University

Paul E. Oberstein is an author at NYU Langone Health specializing in oncology, medicine, and pancreatic cancer.

ORCID

Publications per year

2011–2025

43

Publications

43

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

Andrew D. Rhim, Paul E. Oberstein, Dafydd Thomas et al. · Cancer Cell · 2014 · 2K citations · Full text

, , +13

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

, , +8

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma

Sunil R. Hingorani, Lei Zheng, Andrea J. Bullock et al. · Journal of Clinical Oncology · 2017 · 487 citations

, , +17

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

Eric Van Cutsem, Margaret A. Tempero, Darren Sigal et al. · Journal of Clinical Oncology · 2020 · 446 citations · Full text

, , +14

Pancreatic cancer: why is it so hard to treat?

Paul E. Oberstein, Kenneth P. Olive · Therapeutic Advances in Gastroenterology · 2013 · 345 citations · Full text

, , +14

1–5 of 43